An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, reviving a natural defense against excess uric acid that our ancestors once ...

Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...

A CRISPR-edited crop, goldenberries, which is easier to grow could help expand dietary diversity around the world.

HFA Architecture + Engineering announced today that Sherwood Butler has joined the employee-owned firm as Vice President. He will lead HFA's growing Science + Technology practice following the company ...

AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications validating its POSH (Pooled Optical Screening in Human cells) platform. The study ...

Scribe Therapeutics Inc. (Scribe), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...